2026 NPPES data Infectious Disease Physician NPI 1669716858 M.D.
Verify on CMS →

Mohammed Almanasif, M.D.

Infectious Disease Physician in Fort Wayne, Indiana.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,314 in Infectious Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
427
Medicare Part D claims · 121 beneficiaries · Infectious Disease Physician avg: 816
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$93.66
4 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Mohammed Almanasif, M.D. filed 427 Medicare Part D claims in 2023 as a Infectious Disease Physician in Fort Wayne, Indiana, prescribing 92% generic.

427
Part D claims, 2023
92%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Mohammed Almanasif, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

427 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic, not verified)

Mohammed Almanasif, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Mohammed Almanasif, M.D.?

Quality data not reported

NPI registry status

Active

Issued 11/12/2012

NPI 1669716858

Primary specialty

Infectious Disease Physician

Mid-sized

8,314 US NPIs in this specialty

Medicare Part D claims

427 48% vs specialty avg

2023 prescription claims

Specialty avg: 816

Specialty distribution in Indiana

How Infectious Disease Physician compares to other specialties among Indiana providers

Indiana providers
Behavior Technician - 13.6%Behavior Technician13.6%Student in an Organized Health Care Education/Training Program - 4.7%Student in an Organized Health Care Education/Training Program4.7%Pharmacist - 4.3%Pharmacist4.3%Family Nurse Practitioner - 4.2%Family Nurse Practitioner4.2%Clinical Social Worker - 4.2%Clinical Social Worker4.2%Mental Health Counselor - 4.1%Mental Health Counselor4.1%Infectious Disease Physician - 0.1%Infectious Disease Physician0.1%
Largest specialties in Indiana (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Infectious Disease Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Mohammed Almanasif, M.D. appears in the CMS NPPES registry as an Infectious Disease Physician provider holding M.D. credentials at 11104 PARKVIEW CIRCLE DR STE 440, Fort Wayne, IN, 46845, with a listed phone of (260) 373-9935. NPI 1669716858 was issued on 11/12/2012.

Medicare Part D records for calendar year 2023 show 427 prescription claims written by this provider, covering 121 Medicare beneficiaries and totaling roughly $247K in drug spend, split 8% brand-name and 92% generic by claim count.

Infectious Disease Physician is a mid-sized specialty nationwide, with 8,314 enrolled providers across 54 states and an average of 816 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

11104 PARKVIEW CIRCLE DR STE 440
Fort Wayne, IN 46845

Provider Details

NPI 1669716858
Specialty Infectious Disease Physician
Credentials M.D.
Gender Male
NPI Issued 11/12/2012

Hospital and facility affiliations

Facilities where Mohammed Almanasif, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Parkview Health System Inc
Fort Wayne, IN
Western Michigan University School OF Medicine
Kalamazoo, MI

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mohammed Almanasif, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$94

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

Mohammed Almanasif, M.D. - brand share 8.0%
Infectious Disease Physician average

8% brand-name claims vs 92% generic, on 427 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

427
Total Claims
$247K
Total Drug Cost
121
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
475
Total Day Supply
8,195
Brand vs Generic
8% brand / 92% generic
Brand Drug Cost
$120K
Generic Drug Cost
$127K
Antibiotic Claims
349

Patient Demographics

Average Patient Age
70.6 years
Avg HCC Risk Score
2.28
Gender Split
45% female / 55% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Mohammed Almanasif, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Cefazolin Sodium
46
Ceftriaxone
Ceftriaxone Sodium
38
Daptomycin
34
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
33
Biktarvy
Bictegrav/Emtricit/Tenofov Ala
25
Azithromycin
22
Vancomycin Hcl
22
Piperacillin-Tazobactam
Piperacillin Sodium/Tazobactam
20
Rifampin
20
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
17

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Infectious Disease Physician Overview

How Mohammed Almanasif, M.D. fits within the Infectious Disease Physician landscape nationally.

8,314
Infectious Disease Physician Providers in US
54
States with Infectious Disease Physician
816
Avg Claims per Provider

Mohammed Almanasif, M.D.'s 427 claims are below the specialty average of 816.

Nearby Infectious Disease Physician Providers in Indiana

Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as Almanasif.

Compare Infectious Disease Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Indiana medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Infectious Disease Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Mohammed Almanasif, M.D.'s specialty?
Mohammed Almanasif, M.D. specializes in Infectious Disease Physician and practices in Fort Wayne, Indiana. Credentials: M.D..
How much does Mohammed Almanasif, M.D. prescribe under Medicare Part D?
In 2023, Mohammed Almanasif, M.D. wrote 427 Medicare Part D claims totaling $247K in drug costs for 121 beneficiaries.
Where is Mohammed Almanasif, M.D. located?
Mohammed Almanasif, M.D. is located at 11104 PARKVIEW CIRCLE DR STE 440, Fort Wayne, IN, 46845. Phone: (260) 373-9935.
What is Mohammed Almanasif, M.D.'s NPI number?
Mohammed Almanasif, M.D.'s National Provider Identifier (NPI) is 1669716858, issued on 11/12/2012.
Does Mohammed Almanasif, M.D. prescribe more brand-name or generic drugs?
Mohammed Almanasif, M.D.'s prescribing is 8% brand-name and 92% generic drugs by claim count, with $120K in brand drug costs.
How many Infectious Disease Physician providers are there in the US?
There are 8,314 Infectious Disease Physician providers across 54 states in the US. The average Infectious Disease Physician provider writes 816 Medicare Part D claims per year.
What drugs does Mohammed Almanasif, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Mohammed Almanasif, M.D.'s most frequently prescribed drugs include Cefazolin Sodium, Ceftriaxone, Daptomycin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mohammed Almanasif, M.D. accept Medicare?
Mohammed Almanasif, M.D. appears in CMS Medicare data with 427 Part D claims and 121 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mohammed Almanasif, M.D.'s credentials?
Mohammed Almanasif, M.D.'s NPI is 1669716858 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.